Does BLEOMYCIN Cause Neoplasm progression? 68 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 68 reports of Neoplasm progression have been filed in association with BLEOMYCIN (Bleomycin). This represents 1.0% of all adverse event reports for BLEOMYCIN.
68
Reports of Neoplasm progression with BLEOMYCIN
1.0%
of all BLEOMYCIN reports
44
Deaths
41
Hospitalizations
How Dangerous Is Neoplasm progression From BLEOMYCIN?
Of the 68 reports, 44 (64.7%) resulted in death, 41 (60.3%) required hospitalization, and 2 (2.9%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BLEOMYCIN. However, 68 reports have been filed with the FAERS database.
What Other Side Effects Does BLEOMYCIN Cause?
Off label use (656)
Febrile neutropenia (632)
Neutropenia (433)
Drug ineffective (395)
Pyrexia (291)
Product use in unapproved indication (280)
Pulmonary toxicity (263)
Thrombocytopenia (260)
Nausea (255)
Anaemia (252)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which BLEOMYCIN Alternatives Have Lower Neoplasm progression Risk?
BLEOMYCIN vs BLINATUMOMAB
BLEOMYCIN vs BLONANSERIN
BLEOMYCIN vs --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1
BLEOMYCIN vs BOCEPREVIR
BLEOMYCIN vs BOCOCIZUMAB